PUBLISHER: The Business Research Company | PRODUCT CODE: 1942463
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942463
Blood transfusion devices are medical tools and systems used to safely transfer blood or blood components-such as red cells, plasma, or platelets-from a donor to a patient. They play a vital role in surgeries, trauma care, and the treatment of conditions like anemia and clotting disorders.
The major product categories of blood transfusion devices include pathogen reduction systems, apheresis devices, blood component separators, blood bags and accessories, venous access devices, and others. A pathogen reduction system is a technology designed to minimize or eliminate pathogens from blood products to enhance transfusion safety. The applications include cardiovascular, orthopedic, neurological, obstetric, and gynecological surgeries, among others, and these devices are used by end users such as hospitals, ambulatory surgical centers, blood banks, and others.
Tariffs are impacting the blood transfusion devices market by increasing costs for imported components such as automated separators, pathogen reduction systems, and specialized blood bags. Segments like blood component separators and venous access devices are particularly affected, with regions like Asia-Pacific, including China and India, facing higher import duties. This has resulted in elevated production costs and supply chain adjustments. However, tariffs have also encouraged local manufacturing, innovation in cost-effective device alternatives, and investment in domestic production capabilities.
The blood transfusion devices market research report is one of a series of new reports from The Business Research Company that provides blood transfusion devices market statistics, including blood transfusion devices industry global market size, regional shares, competitors with a blood transfusion devices market share, detailed blood transfusion devices market segments, market trends and opportunities, and any further data you may need to thrive in the blood transfusion devices industry. This blood transfusion devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The blood transfusion devices market size has grown strongly in recent years. It will grow from $5.45 billion in 2025 to $5.84 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to reliance on manual blood transfusion methods, limited access to advanced pathogen reduction systems, increasing number of surgical procedures, rising hospital and blood bank infrastructures, growing awareness of transfusion safety.
The blood transfusion devices market size is expected to see strong growth in the next few years. It will grow to $7.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to technological advancements in automated apheresis and component separators, increasing demand for minimally invasive surgical procedures, expansion of blood bank networks, rising regulatory standards for transfusion devices, integration of smart monitoring and digital tracking in transfusion systems. Major trends in the forecast period include rising adoption of automated blood component separation systems, increasing use of pathogen reduction technologies, expansion of blood bag and accessory innovations, growth in specialized venous access devices, rising demand for blood storage and transfusion equipment.
The rise in accidents and trauma cases is expected to propel the growth of the blood transfusion devices market going forward. Accidents and trauma cases are increasing due to rapid urbanization, higher vehicle usage, and unsafe road conditions. Blood transfusion devices are crucial in trauma and accident scenarios, as they enable the rapid administration of life-saving blood products to stabilize patients and manage severe bleeding. For instance, in July 2024, according to the National Safety Council Injury Facts, a US-based safety organization, motor vehicle fatalities in the United States reached 20,900 during the first half of 2024, remaining nearly unchanged from 20,930 fatalities recorded during the same period in 2023, despite a 0.8% increase in mileage from 2023 and a 3.1% rise from 2022. Therefore, the increasing number of accidents and trauma cases is driving the growth of the blood transfusion devices market.
Leading companies operating in the blood transfusion devices market are focusing on developing advanced blood grouping and testing solutions to strengthen their competitive position. Blood grouping and testing solutions include medical devices and reagents used to determine blood type and ensure transfusion compatibility. For example, in June 2024, Innobiochips, a France-based biopharmaceutical company, launched Omnys, an innovative blood transfusion device designed to improve laboratory productivity and accuracy through multiplex analysis. The system enables high-resolution testing of blood components, including standard ABO/D typing and extended phenotyping, while reducing the number of testing wells required and minimizing waste.
In March 2023, Werfen S.A., a Spain-based biomaterials manufacturer, acquired Immucor Inc. for $2 billion. This acquisition strengthens Werfen's position in the transfusion and transplant markets while expanding its portfolio across hemostasis, acute care, and autoimmunity. Immucor Inc. is a US-based provider of blood transfusion devices.
Major companies operating in the blood transfusion devices market are BAG Health Care GmbH, Grifols S.A., Bio-Rad Laboratories Inc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, Siemens Healthineers, Beckman Coulter Inc., Diagast SAS, QuidelOrtho Corporation, Danaher Corporation, Becton Dickinson and Company, Quotient Biodiagnostics, Sysmex Corporation, HemoCue AB, Agena Bioscience Inc., Tulip Diagnostics P Ltd, Merck KGaA, Trinity Biotech, MTC Med Testconsult GmbH, BioMedomics Inc, Agappe Diagnostics Ltd, Day Medical SA
North America was the largest region in the blood transfusion devices market in 2025. The regions covered in the blood transfusion devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the blood transfusion devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The blood transfusion devices market consists of sales of blood warmers, needles, catheters, and filters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Blood Transfusion Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses blood transfusion devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for blood transfusion devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood transfusion devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.